Home > News > UNeMed and Telomolecular Sign License for Nanoparticle Use
January 31st, 2006
UNeMed and Telomolecular Sign License for Nanoparticle Use
Abstract:
Telomolecular Corp., a biotechnology company, that develops biopharmaceutical therapies designed to treat aging and age-related disease, today announced the signing of a global licensing agreement with UNeMed, Omaha Nebraska, the licensing agent for the University of Nebraska Medical Center, a leading licensor of advanced medical and biomedical products and patents.
Source:
prweb
Bookmark:
Nanomedicine
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
European Technology Platform for Nanomedicine and Nanomed2020 European Consortium Launch the Nanomedicine Award June 17th, 2013
Materials
Working backward: Computer-aided design of zeolite templates: Rice scientists apply drug-design lessons to production of industrial minerals June 17th, 2013
Discover the ‘Nanostructure Advantage’ at ECerS 2013, Booth 5: Innovnano presents nanostructured powders for high performance ceramics June 17th, 2013
Discovery of new material state counterintuitive to laws of physics June 14th, 2013
Ceramics in Paper Manufacturing including Advanced and Nano Materials: Author- Dr. Mahendra Patel, 420 pages; 32 chapters, Publ.2013 June 12th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013